These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29077422)

  • 21. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
    Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM
    An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Overview of measles, mumps, rubella and varicella vaccination in adolescents and adults].
    Quast U; Arndt U
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S77-81. PubMed ID: 19353476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative measles incidence among exposed military and nonmilitary persons in Anchorage, Alaska.
    Glover DJ; DeMain J; Herbold JR; Schneider PJ; Bunning M
    Mil Med; 2004 Jul; 169(7):515-7. PubMed ID: 15291181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry.
    Ramondetti F; Sacco S; Comelli M; Bruno G; Falorni A; Iannilli A; d'Annunzio G; Iafusco D; Songini M; Toni S; Cherubini V; Carle F;
    Diabet Med; 2012 Jun; 29(6):761-6. PubMed ID: 22133003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
    Leung JH; Hirai HW; Tsoi KK
    Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare workers and immunity to infectious diseases.
    Vagholkar S; Ng J; Chan RC; Bunker JM; Zwar NA
    Aust N Z J Public Health; 2008 Aug; 32(4):367-71. PubMed ID: 18782402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paediatric Active Enhanced Disease Surveillance inaugural annual report, 2014.
    Zurynski YA; McRae JE; Quinn HE; Wood NJ; Macartney KK
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E391-E400. PubMed ID: 28278415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
    Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal measles-mumps-rubella vaccination to new recruits and the incidence of mumps in the military.
    Moon JY; Jung J; Huh K
    Vaccine; 2017 Jul; 35(32):3913-3916. PubMed ID: 28633890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Measles, mumps, rubella and varicella: antibody titration and vaccinations in a large hospital].
    Cologni L; Belotti L; Bacis M; Moioli F; Goglio A; Mosconi G
    G Ital Med Lav Ergon; 2012; 34(3 Suppl):272-4. PubMed ID: 23405639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits.
    Struewing JP; Hyams KC; Tueller JE; Gray GC
    Am J Public Health; 1993 Dec; 83(12):1717-20. PubMed ID: 8259801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
    Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles, rubella, and varicella among the crew of a cruise ship sailing from Florida, United States, 2006.
    Mitruka K; Felsen CB; Tomianovic D; Inman B; Street K; Yambor P; Reef SE
    J Travel Med; 2012 Jul; 19(4):233-7. PubMed ID: 22776384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination coverage and immunity levels against vaccine-preventable diseases in male Air Force recruits in Greece.
    Maltezou HC; Karantoni H; Petrikkos P; Georgota P; Katerelos P; Liona A; Tsagarakis S; Theodoridou M; Hatzigeorgiou D
    Vaccine; 2020 Jan; 38(5):1181-1185. PubMed ID: 31761499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers].
    Oliveira J; da Cunha S; Côrte-Real R; Sampaio L; Dais N; Meliço-Silvestre A
    Acta Med Port; 1995 Apr; 8(4):206-16. PubMed ID: 7625214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling Hospitalisation Ratios for Febrile Convulsions and Severe Varicella Under Combined Measles, Mumps, Rubella, and Varicella (MMRV-Priorix-Tetra™) Compared to Separate MMR + V Vaccination.
    Bauchau V; Van Holle L; Cohen C
    Drug Saf; 2015 Nov; 38(11):1095-102. PubMed ID: 26251259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.